This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rao, C. V. Articles by Reddy, B. S. Search for Related Content PubMed PubMed Citation Articles by Rao, C. V. Articles by Reddy, B. S.

Chemoprevention of Colon Carcinogenesis by Dietary Curcumin, a Naturally Occurring Plant Phenolic Compound¹

Divisions of Nutritional Carcinogenesis [C. V. R., B. S., B. S. R.] Pathology [A. R.], American Health Foundation, Valhalla, New York 10595

Human epidemiological and laboratory animal model studies have suggested that nonsteroidal antiinflammatory drugs reduce the risk of development of colon cancer and that the inhibition of colon carcinogenesis is mediated through the alteration in cyclooxygenase metabolism of arachidonic acid. Curcumin, which is a naturally occurring compound, is present in turmeric, possesses both antiinflammatory and antioxidant properties, and has been tested for its chemopreventive properties in skin and forestomach carcinogenesis. The present study was designed to investigate the chemopreventive action of dietary curcumin on azozymethaneinduced colon carcinogenesis and also the modulating effect of this agent on the colonic mucosal and tumor phospholipase A₂, phospholipase C1, lipoxygenase, and cyclooxygenase activities in male F344 rats. At 5 weeks of age, groups of animals were fed the control (modified AIN-76A) diet or a diet containing 2000 ppm of curcumin. At 7 weeks of age, all animals, except those in the vehicle (normal saline)-treated groups, were given two weekly s.c. injections of azoxymethane at a dose rate of 15 mg/kg body weight. All groups were continued on their respective dietary regimen until the termination of the experiment at 52 weeks after the carcinogen treatment. Colonic tumors were evaluated histopathologically. Colonic mucosa and tumors were analyzed for phospholipase A₂, phospholipase C1, ex vivo prostaglandin (PG) E₂, cyclooxygenase, and lipoxygenase activities. The results indicate that dietary administration of curcumin significantly inhibited incidence of colon adenocarcinomas (P < 0.004) and the multiplicity of invasive (P < 0.015), noninvasive (P < 0.01), and total (invasive plus noninvasive) adenocarcinomas (P < 0.001). Dietary curcumin also significantly suppressed the colon tumor volume by >57% compared to the control diet. Animals fed the curcumin diet showed decreased activities of colonic mucosal and tumor phospholipase A₂ (50%) and phospholipase C1 (40%) and levels of PGE₂ (>38%). The formation of prostaglandins such as PGE₂, PGF₂, PGD₂, 6-keto PGF₁, and thromboxane B₂ through the cyclooxygenase system and production of 5(S)-, 8(S)-, 12(S)-, and 15(S)-hydroxyeicosatetraenoic acids via the lipoxygenase pathway from arachidonic acid were reduced in colonic mucosa and tumors of animals fed the curcumin diet as compared to control diet. Although the precise mechanism by which curcumin inhibits colon tumorigenesis remains to be elucidated, it is likely that the chemopreventive action, at least in part, may be related to the modulation of arachidonic acid metabolism.

¹ Supported by USPHS Grant CA 17613 awarded by the National Cancer Institute.

² To whom requests for reprints should be addressed, at Division of Nutritional Carcinogenesis, One Dana Road, American Health Foundation, Valhalla, NY 10595.

Received 7/25/94. Accepted 11/10/94.

This article has been cited by other articles:

				C. V. Rao, V. E. Steele, M. V. Swamy, J. M.R. Patlolla, S. Guruswamy, and L. Kopelovich Inhibition of Azoxymethane-Induced Colorectal Cancer by CP-31398, a TP53 Modulator, Alone or in Combination with Low Doses of Celecoxib in Male F344 Rats Cancer Res., October 15, 2009; 69(20): 8175 - 8182. [Abstract] [Full Text] [PDF]

				A. Koeberle, H. Northoff, and O. Werz Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1 Mol. Cancer Ther., August 1, 2009; 8(8): 2348 - 2355. [Abstract] [Full Text] [PDF]

				A.R.M. R. Amin, O. Kucuk, F. R. Khuri, and D. M. Shin Perspectives for Cancer Prevention With Natural Compounds J. Clin. Oncol., June 1, 2009; 27(16): 2712 - 2725. [Abstract] [Full Text] [PDF]

				B. GIRI, A. GOMES, R. SENGUPTA, S. BANERJEE, J. NAUTIYAL, F. H. SARKAR, and A. P.N. MAJUMDAR Curcumin Synergizes the Growth Inhibitory Properties of Indian Toad (Bufo melanostictus Schneider) Skin-derived Factor (BM-ANF1) in HCT-116 Colon Cancer Cells Anticancer Res, January 1, 2009; 29(1): 395 - 401. [Abstract] [Full Text] [PDF]

				N. K. Basu, L. Kole, M. Basu, K. Chakraborty, P. S. Mitra, and I. S. Owens The Major Chemical-detoxifying System of UDP-glucuronosyltransferases Requires Regulated Phosphorylation Supported by Protein Kinase C J. Biol. Chem., August 22, 2008; 283(34): 23048 - 23061. [Abstract] [Full Text] [PDF]

				R. Garg, A. G. Ramchandani, and G. B. Maru Curcumin decreases 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C translocation to modulate downstream targets in mouse skin Carcinogenesis, June 1, 2008; 29(6): 1249 - 1257. [Abstract] [Full Text] [PDF]

				R. Garg, S. Gupta, and G. B. Maru Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: mechanism of its anti-initiating action Carcinogenesis, May 1, 2008; 29(5): 1022 - 1032. [Abstract] [Full Text] [PDF]

				S. Salvioli, E. Sikora, E. L. Cooper, and C. Franceschi Curcumin in Cell Death Processes: A Challenge for CAM of Age-Related Pathologies Evid. Based Complement. Altern. Med., June 1, 2007; 4(2): 181 - 190. [Abstract] [Full Text] [PDF]

				D. Deeb, H. Jiang, X. Gao, S. Al-Holou, A. L. Danyluk, S. A. Dulchavsky, and S. C. Gautam Curcumin [1,7-Bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] Sensitizes Human Prostate Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand/Apo2L-Induced Apoptosis by Suppressing Nuclear Factor-{kappa}B via Inhibition of the Prosurvival Akt Signaling Pathway J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 616 - 625. [Abstract] [Full Text] [PDF]

				L. Li, B. Ahmed, K. Mehta, and R. Kurzrock Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer Mol. Cancer Ther., April 1, 2007; 6(4): 1276 - 1282. [Abstract] [Full Text] [PDF]

				H. Choi, Y.-S. Chun, S.-W. Kim, M.-S. Kim, and J.-W. Park Curcumin Inhibits Hypoxia-Inducible Factor-1 by Degrading Aryl Hydrocarbon Receptor Nuclear Translocator: A Mechanism of Tumor Growth Inhibition Mol. Pharmacol., November 1, 2006; 70(5): 1664 - 1671. [Abstract] [Full Text] [PDF]

				W. Chearwae, S. Shukla, P. Limtrakul, and S. V. Ambudkar Modulation of the function of the multidrug resistance-linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin. Mol. Cancer Ther., August 1, 2006; 5(8): 1995 - 2006. [Abstract] [Full Text] [PDF]

				C. V. Rao, B. S. Reddy, V. E. Steele, C-X Wang, X. Liu, N. Ouyang, J. M.R. Patlolla, B. Simi, L. Kopelovich, and B. Rigas Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets. Mol. Cancer Ther., June 1, 2006; 5(6): 1530 - 1538. [Abstract] [Full Text] [PDF]

				J. W. FINLEY Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids, Glucosinolates, Polyphenols and Selenocompounds Ann. Bot., June 1, 2005; 95(7): 1075 - 1096. [Abstract] [Full Text] [PDF]

				G. Garcea, D. P. Berry, D. J.L. Jones, R. Singh, A. R. Dennison, P. B. Farmer, R. A. Sharma, W. P. Steward, and A. J. Gescher Consumption of the Putative Chemopreventive Agent Curcumin by Cancer Patients: Assessment of Curcumin Levels in the Colorectum and their Pharmacodynamic Consequences Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 120 - 125. [Abstract] [Full Text] [PDF]

				R. A. Sharma, S. A. Euden, S. L. Platton, D. N. Cooke, A. Shafayat, H. R. Hewitt, T. H. Marczylo, B. Morgan, D. Hemingway, S. M. Plummer, et al. Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance Clin. Cancer Res., October 15, 2004; 10(20): 6847 - 6854. [Abstract] [Full Text] [PDF]

				Y. Song, N. D. Sonawane, D. Salinas, L. Qian, N. Pedemonte, L. J. V. Galietta, and A. S. Verkman Evidence against the Rescue of Defective {Delta}F508-CFTR Cellular Processing by Curcumin in Cell Culture and Mouse Models J. Biol. Chem., September 24, 2004; 279(39): 40629 - 40633. [Abstract] [Full Text] [PDF]

				J. Hong, M. Bose, J. Ju, J.-H. Ryu, X. Chen, S. Sang, M.-J. Lee, and C. S. Yang Modulation of arachidonic acid metabolism by curcumin and related {beta}-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase Carcinogenesis, September 1, 2004; 25(9): 1671 - 1679. [Abstract] [Full Text] [PDF]

				P. J. Moos, K. Edes, J. E. Mullally, and F. A. Fitzpatrick Curcumin impairs tumor suppressor p53 function in colon cancer cells Carcinogenesis, September 1, 2004; 25(9): 1611 - 1617. [Abstract] [Full Text] [PDF]

				D. Deeb, H. Jiang, X. Gao, M. S. Hafner, H. Wong, G. Divine, R. A. Chapman, S. A. Dulchavsky, and S. C. Gautam Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-{kappa}B through suppression of I{kappa}B{alpha} phosphorylation Mol. Cancer Ther., July 1, 2004; 3(7): 803 - 812. [Abstract] [Full Text] [PDF]

				H.-Y. Lee, Y.-A. Suh, J. W. Kosmeder, J. M. Pezzuto, W. K. Hong, and J. M. Kurie Deguelin-Induced Inhibition of Cyclooxygenase-2 Expression in Human Bronchial Epithelial Cells Clin. Cancer Res., February 1, 2004; 10(3): 1074 - 1079. [Abstract] [Full Text] [PDF]

				Curcumin Derivatives: Potential for Prostate Cancer Management: ADDANKI P. KUMAR, GRETCHEN E. GARCIA, RITA GHOSH, RAJENDRAN V. RAJNARAYANAN,1 WILLIAM L. ALWORTH,1 AND THOMAS J. SLAGA, Center for Cancer Causation and Prevention, AMC Cancer Research Center and University of Colorado Comprehensive Cancer Center, Denver, Colorado 80214; 1 Department of Chemistry, Tulane University, New Orleans, Louisiana 70118 Toxicol Pathol, January 1, 2004; 32(1): 161 - 163. [PDF]

				P. K Shukla, V. K Khanna, M. Y Khan, and R. C Srimal Protective effect of curcumin against lead neurotoxicity in rat Human and Experimental Toxicology, December 1, 2003; 22(12): 653 - 658. [Abstract] [PDF]

				H. Y. Kim, E. J. Park, E.-h. Joe, and I. Jou Curcumin Suppresses Janus Kinase-STAT Inflammatory Signaling through Activation of Src Homology 2 Domain-Containing Tyrosine Phosphatase 2 in Brain Microglia J. Immunol., December 1, 2003; 171(11): 6072 - 6079. [Abstract] [Full Text] [PDF]

				A. H. Conney Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture Cancer Res., November 1, 2003; 63(21): 7005 - 7031. [Abstract] [Full Text] [PDF]

				J. W Lampe Spicing up a vegetarian diet: chemopreventive effects of phytochemicals Am. J. Clinical Nutrition, September 1, 2003; 78(3): 579S - 583. [Abstract] [Full Text] [PDF]

				S. Shishodia, P. Potdar, C. G. Gairola, and B. B. Aggarwal Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-{kappa}B activation through inhibition of I{kappa}B{alpha} kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1 Carcinogenesis, July 1, 2003; 24(7): 1269 - 1279. [Abstract] [Full Text] [PDF]

				B. Salh, K. Assi, V. Templeman, K. Parhar, D. Owen, A. Gomez-Munoz, and K. Jacobson Curcumin attenuates DNB-induced murine colitis Am J Physiol Gastrointest Liver Physiol, June 9, 2003; 285(1): G235 - G243. [Abstract] [Full Text] [PDF]

				A. C. Bharti, N. Donato, S. Singh, and B. B. Aggarwal Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and Ikappa Balpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis Blood, February 1, 2003; 101(3): 1053 - 1062. [Abstract] [Full Text] [PDF]

				D. Deeb, Y. X. Xu, H. Jiang, X. Gao, N. Janakiraman, R. A. Chapman, and S. C. Gautam Curcumin (Diferuloyl-Methane) Enhances Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis in LNCaP Prostate Cancer Cells Mol. Cancer Ther., January 1, 2003; 2(1): 95 - 103. [Abstract] [Full Text] [PDF]

				S. E Ebeler, C. A Brenneman, G.-S. Kim, W. T Jewell, M. R Webb, L. Chacon-Rodriguez, E. A MacDonald, A. C Cramer, A. Levi, J. D Ebeler, et al. Dietary catechin delays tumor onset in a transgenic mouse model Am. J. Clinical Nutrition, October 1, 2002; 76(4): 865 - 872. [Abstract] [Full Text] [PDF]

				A. L. Rinaldi, M. A. Morse, H. W. Fields, D. A. Rothas, P. Pei, K. A. Rodrigo, R. J. Renner, and S. R. Mallery Curcumin Activates the Aryl Hydrocarbon Receptor yet Significantly Inhibits (-)-Benzo(a)pyrene-7R-trans-7,8-dihydrodiol Bioactivation in Oral Squamous Cell Carcinoma Cells and Oral Mucosa Cancer Res., October 1, 2002; 62(19): 5451 - 5456. [Abstract] [Full Text] [PDF]

				J. L. Quiles, M. D. Mesa, C. L. Ramirez-Tortosa, C. M. Aguilera, M. Battino, A. Gil, and M. C. Ramirez-Tortosa Curcuma longa Extract Supplementation Reduces Oxidative Stress and Attenuates Aortic Fatty Streak Development in Rabbits Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1225 - 1231. [Abstract] [Full Text] [PDF]

				S. Perkins, R. D. Verschoyle, K. Hill, I. Parveen, M. D. Threadgill, R. A. Sharma, M. L. Williams, W. P. Steward, and A. J. Gescher Chemopreventive Efficacy and Pharmacokinetics of Curcumin in the Min/+ Mouse, a Model of Familial Adenomatous Polyposis Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 535 - 540. [Abstract] [Full Text] [PDF]

				J. I. Fenton, M. S. Wolff, M. W. Orth, and N. G. Hord Membrane-type matrix metalloproteinases mediate curcumin-induced cell migration in non-tumorigenic colon epithelial cells differing in Apc genotype Carcinogenesis, June 1, 2002; 23(6): 1065 - 1070. [Abstract] [Full Text] [PDF]

				J. M. Wallace Nutritional and Botanical Modulation of the Inflammatory Cascade--Eicosanoids, Cyclooxygenases, and Lipoxygenases-- As an Adjunct in Cancer Therapy Integr Cancer Ther, March 1, 2002; 1(1): 7 - 37. [Abstract] [PDF]

				C. R. Ireson, D. J. L. Jones, S. Orr, M. W. H. Coughtrie, D. J. Boocock, M. L. Williams, P. B. Farmer, W. P. Steward, and A. J. Gescher Metabolism of the Cancer Chemopreventive Agent Curcumin in Human and Rat Intestine Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 105 - 111. [Abstract] [Full Text]

				R. J. Anto, A. Mukhopadhyay, K. Denning, and B. B. Aggarwal Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl Carcinogenesis, January 1, 2002; 23(1): 143 - 150. [Abstract] [Full Text] [PDF]

				M. J. Wargovich, C. Woods, D. M. Hollis, and M. E. Zander Herbals, Cancer Prevention and Health J. Nutr., November 1, 2001; 131(11): 3034S - 3036. [Abstract] [Full Text] [PDF]

				N. Hill-Kapturczak, V. Thamilselvan, F. Liu, H. S. Nick, and A. Agarwal Mechanism of heme oxygenase-1 gene induction by curcumin in human renal proximal tubule cells Am J Physiol Renal Physiol, November 1, 2001; 281(5): F851 - F859. [Abstract] [Full Text] [PDF]

				I. Shureiqi and S. M. Lippman Lipoxygenase Modulation to Reverse Carcinogenesis Cancer Res., September 1, 2001; 61(17): 6307 - 6312. [Abstract] [Full Text] [PDF]

				K. Okada, C. Wangpoengtrakul, T. Tanaka, S. Toyokuni, K. Uchida, and T. Osawa Curcumin and Especially Tetrahydrocurcumin Ameliorate Oxidative Stress-Induced Renal Injury in Mice J. Nutr., August 1, 2001; 131(8): 2090 - 2095. [Abstract] [Full Text] [PDF]

				R A Sharma, A J Gescher, K J O'Byrne, and W P Steward Familiar drugs may prevent cancer Postgrad. Med. J., August 1, 2001; 77(910): 492 - 497. [Abstract] [Full Text] [PDF]

				R. A. Sharma, H. R. McLelland, K. A. Hill, C. R. Ireson, S. A. Euden, M. M. Manson, M. Pirmohamed, L. J. Marnett, A. J. Gescher, and W. P. Steward Pharmacodynamic and Pharmacokinetic Study of Oral Curcuma Extract in Patients with Colorectal Cancer Clin. Cancer Res., July 1, 2001; 7(7): 1894 - 1900. [Abstract] [Full Text] [PDF]

				W. Takabe, E. Niki, K. Uchida, S. Yamada, K. Satoh, and N. Noguchi Oxidative stress promotes the development of transformation: involvement of a potent mutagenic lipid peroxidation product, acrolein Carcinogenesis, June 1, 2001; 22(6): 935 - 941. [Abstract] [Full Text] [PDF]

				R. A. Sharma, C. R. Ireson, R. D. Verschoyle, K. A. Hill, M. L. Williams, C. Leuratti, M. M. Manson, L. J. Marnett, W. P. Steward, and A. Gescher Effects of Dietary Curcumin on Glutathione S-Transferase and Malondialdehyde-DNA Adducts in Rat Liver and Colon Mucosa: Relationship with Drug Levels1 Clin. Cancer Res., May 1, 2001; 7(5): 1452 - 1458. [Abstract] [Full Text]

				K. Imaida, S. Tamano, K. Kato, Y. Ikeda, M. Asamoto, S. Takahashi, Z. Nir, M. Murakoshi, H. Nishino, and T. Shirai Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis Carcinogenesis, March 1, 2001; 22(3): 467 - 472. [Abstract] [Full Text] [PDF]

				W. Q. Li, F. Dehnade, and M. Zafarullah Oncostatin M-Induced Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinase-3 Genes Expression in Chondrocytes Requires Janus Kinase/STAT Signaling Pathway J. Immunol., March 1, 2001; 166(5): 3491 - 3498. [Abstract] [Full Text] [PDF]

				C. Ireson, S. Orr, D. J. L. Jones, R. Verschoyle, C.-K. Lim, J.-L. Luo, L. Howells, S. Plummer, R. Jukes, M. Williams, et al. Characterization of Metabolites of the Chemopreventive Agent Curcumin in Human and Rat Hepatocytes and in the Rat in Vivo, and Evaluation of Their Ability to Inhibit Phorbol Ester-induced Prostaglandin E2 Production Cancer Res., February 1, 2001; 61(3): 1058 - 1064. [Abstract] [Full Text]

				J. M. Mariadason, G. A. Corner, and L. H. Augenlicht Genetic Reprogramming in Pathways of Colonic Cell Maturation Induced by Short Chain Fatty Acids: Comparison with Trichostatin A, Sulindac, and Curcumin and Implications for Chemoprevention of Colon Cancer Cancer Res., August 1, 2000; 60(16): 4561 - 4572. [Abstract] [Full Text]

				J. M. MEI, N. G. HORD, D. F. WINTERSTEIN, S. P. DONALD, and J. M. PHANG Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized murine colonic epithelial cells FASEB J, June 1, 2000; 14(9): 1188 - 1201. [Abstract] [Full Text]

				N. N. Mahmoud, A. M. Carothers, D. Grunberger, R. T. Bilinski, M. R. Churchill, C. Martucci, H. L. Newmark, and M. M. Bertagnolli Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis Carcinogenesis, May 1, 2000; 21(5): 921 - 927. [Abstract] [Full Text] [PDF]

				B. S. Reddy Novel Approaches to the Prevention of Colon Cancer by Nutritional Manipulation and Chemoprevention Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 239 - 247. [Abstract] [Full Text]

				S.E. Chuang, M.L. Kuo, C.H. Hsu, C.R. Chen, J.K. Lin, G.M. Lai, C.Y. Hsieh, and A.L. Cheng Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis Carcinogenesis, February 1, 2000; 21(2): 331 - 335. [Abstract] [Full Text] [PDF]

				R.-L. Hong, W. H. Spohn, and M.-C. Hung Curcumin Inhibits Tyrosine Kinase Activity of p185neu and Also Depletes p185neu Clin. Cancer Res., July 1, 1999; 5(7): 1884 - 1891. [Abstract] [Full Text] [PDF]

				H. Inano, M. Onoda, N. Inafuku, M. Kubota, Y. Kamada, T. Osawa, H. Kobayashi, and K. Wakabayashi Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with {gamma}-rays Carcinogenesis, June 1, 1999; 20(6): 1011 - 1018. [Abstract] [Full Text] [PDF]

				P. Michaluart, J. L. Masferrer, A. M. Carothers, K. Subbaramaiah, B. S. Zweifel, C. Koboldt, J. R. Mestre, D. Grunberger, P. G. Sacks, T. Tanabe, et al. Inhibitory Effects of Caffeic Acid Phenethyl Ester on the Activity and Expression of Cyclooxygenase-2 in Human Oral Epithelial Cells and in a Rat Model of Inflammation Cancer Res., May 1, 1999; 59(10): 2347 - 2352. [Abstract] [Full Text] [PDF]

				M.-H. Pan, T.-M. Huang, and J.-K. Lin Biotransformation of Curcumin Through Reduction and Glucuronidation in Mice Drug Metab. Dispos., April 1, 1999; 27(4): 486 - 494. [Abstract] [Full Text]

				F. Zhang, N. K. Altorki, J. R. Mestre, K. Subbaramaiah, and A. J. Dannenberg Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells Carcinogenesis, March 1, 1999; 20(3): 445 - 451. [Abstract] [Full Text] [PDF]

				T. Kawamori, R. Lubet, V. E. Steele, G. J. Kelloff, R. B. Kaskey, and C. V. Rao Chemopreventive Effect of Curcumin, a Naturally Occurring Anti-Inflammatory Agent, during the Promotion/Progression Stages of Colon Cancer Cancer Res., February 1, 1999; 59(3): 597 - 601. [Abstract] [Full Text] [PDF]